Ignite Creation Date:
2024-05-06 @ 4:40 PM
Last Modification Date:
2024-10-26 @ 2:14 PM
Study NCT ID:
NCT05054751
Status:
COMPLETED
Last Update Posted:
2022-06-13
First Post:
2021-08-13
Brief Title:
GB491 Combined With Fulvestrant for HR HER2- Locally Advanced or Metastatic Breast Cancer
Sponsor:
Genor Biopharma Co Ltd
Organization:
Genor Biopharma Co Ltd
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-09-10
Start Date Type:
ACTUAL
Primary Completion Date:
2023-10-31
Primary Completion Date Type:
ESTIMATED
Completion Date:
2024-01-31
Completion Date Type:
ESTIMATED
First Submit Date:
2021-08-13
First Submit QC Date:
September 22 2021
Study First Post Date:
2021-09-23
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-10-07
Last Update Post Date:
2022-06-13
Last Update Post Date Type:
ACTUAL